top of page
News, Events and Updates
Search
2016 Rett Syndrome Symposium
Jun 14, 2016
Sigma-1 Receptor Agonists as Potential Treatment Options for Autism Spectrum Disorders
Jun 10, 2016
AAT Presentation
Jun 10, 2016
Anavex Announces Positive Preclinical Results w/ ANAVEX 2-73 in Fragile X — Autism-Related Disorders
Jun 5, 2016
Anavex Announces U.S. FDA Orphan Drug Designation to ANAVEX 2-73 for the Treatment of Rett Syndrome
May 19, 2016
Anavex Announces Positive Preclinical Data for ANAVEX 2-73 in Infantile Spasms
May 17, 2016
Anavex Reports Fiscal Second Quarter 2016 Financial Results
May 10, 2016
Speaker Session: BIO 2016 International Convention
May 2, 2016
U.S. FDA Grants Orphan Drug Designation to ANAVEX 3-71 for the Treatment of Frontotemporal Dementia
Apr 7, 2016
33rd Camerino-Cyprus Symposium
Apr 5, 2016
Anavex Annual Stockholders Meeting
Apr 5, 2016
29
30
31
32
33
Stay Connected
Follow us on social media
Newsroom
Webcast Library
Contact Us
Back to Newsroom
bottom of page
